CLINICAL_TRIALS trial_result · 2025-02-26

Clinical Trial Update: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia [Phase 3]

Phase 3 study NCT02688140 in newly diagnosed, high-risk Acute Promyelocytic Leukemia has completed. The entry notes the trial status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Technische Universität Dresden | Conditions: Acute Promyelocytic Leukemia | Phase 3 | Status: COMPLETED